As Two Cancer Compounds Progress, Peregrine Focuses On Partner Search
This article was originally published in The Pink Sheet Daily
Executive Summary
Brain cancer candidate Cotara could move into Phase III by late 2009, CEO King tells “The Pink Sheet” DAILY.